SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-024878
Filing Date
2024-03-04
Accepted
2024-03-04 16:52:52
Documents
14
Period of Report
2024-03-04
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vktx-20240304.htm   iXBRL 8-K 44882
2 EX-99.1 vktx-ex99_1.htm EX-99.1 18246
3 GRAPHIC img201808844_0.jpg GRAPHIC 11467
  Complete submission text file 0000950170-24-024878.txt   204270

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT vktx-20240304.xsd EX-101.SCH 30714
15 EXTRACTED XBRL INSTANCE DOCUMENT vktx-20240304_htm.xml XML 4719
Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37355 | Film No.: 24715510
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)